Abstract:Objective:To explore the different administration routes of ambroxol hydrochloride combined with montelukast sodium om serum levels of matrix metalloproteinase-9 (MMP-9), tissue inhibitor of metalloproteinase-1(TIMP-1) and interleukin-6 (IL-6) in children patients with asthma. Methods:84 cases of children patients with asthma admitted to our hospital were evenly divided into atomization group and intravenous drip group according to the random number table method. On the basis of conventional treatment and montelukast sodium chewable tablets, atomization group was given atomization inhalation of ambroxol hydrochloride, and intravenous drip group was given intravenous drip of ambroxol hydrochloride. Clinical efficacy, disappearance times of symptoms and signs, pulmonary ventilation function and serum markers were compared between the two groups. Results:After treatment, the total effective rate in atomization group was significantly higher than that in intravenous drip group (95.24% vs 76.19%) (P<0.05). The disappearance times of fever, asthma, cough and lung rale in atomization group were earlier than that in intravenous drip group (P<0.05). There were no significant differences in the levels of pulmonary artery resistance index (RI), pulmonary shunt rate (Qs/Qt), partial pressure difference of alveolar-arterial oxygen (PA-aDO2), maximal inspiratory pressure (PIMAX), serum MMP-9, TIMP-1, IL-6 and osteopontin (OPN) between the two groups before treatment (P>0.05), but the differences of above indexes before and after treatment in atomization group were greater than those in intravenous drip group (P<0.05). Conclusions: Ambroxol hydrochloride combined with montelukast sodium can effectively control the condition of children with asthma, and the efficacy of aerosol inhalation is better than intravenous drip, which may be related to the reduction of serum levels of MMP-9, TIMP-1, IL-6 and OPN.
路芳, 朱艳. 盐酸氨溴索不同给药途径联合孟鲁司特钠治疗对哮喘患儿血清MMP-9 TIMP-1 IL-6水平的影响[J]. 河北医学, 2019, 25(8): 1265-1268.
LU Fang, ZHU Yan. Effects of Ambroxol Hydrochloride combined with Montelukast Sodium on Serum Levels of MMP-9 TIMP-1 and IL-6 in Children with Asthma. HeBei Med, 2019, 25(8): 1265-1268.